Re-invigorating rather than re-inventing the wheel: augmenting the impact of salvage autologous stem cell transplantation for multiple myeloma in the era of novel agents

被引：2
|
作者：
Cook, G. [1 ]
机构：
[1] Univ Leeds, Dept Haematol, Transplant Immunol Grp, Sect Expt Haematol,Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷 / 10期
关键词：
HIGH-DOSE MELPHALAN; BORTEZOMIB; DEXAMETHASONE; THERAPY; PHASE-2; RELAPSE; TRIAL;
D O I：
10.1038/bmt.2015.175
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1269 / 1270
页数：2
相关论文
共 50 条
  • [11] Autologous Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel Therapies
    Parrondo, Ricardo D.
    Ailawadhi, Sikander
    Sher, Taimur
    Chanan-Khan, Asher A.
    Roy, Vivek
    JCO ONCOLOGY PRACTICE, 2020, 16 (02) : 56 - +
  • [12] Outcome of autologous stem cell transplantation in multiple myeloma, in the era of novel agents: a single-centre experience
    Bafna, V.
    Damodar, S.
    Bendi, C.
    LEUKEMIA RESEARCH, 2019, 85 : S41 - S41
  • [13] Impact of Maintenance Therapy after Salvage Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma
    Kaedbey, Rayan
    Hay, Kevin
    Masih-Khan, Esther
    Kardjadj, Moustafa
    McCurdy, Arleigh
    Chu, Michael P.
    Jimenez-Zepeda, Victor H.
    Leblanc, Richard
    Song, Kevin
    Mian, Hira S.
    Louzada, Martha L.
    Sebag, Michael
    Reiman, Anthony
    White, Darrell J.
    Venner, Christopher P.
    Stakiw, Julie
    Kotb, Rami
    Aslam, Muhammad
    Bergstrom, Debra
    Gul, Engin
    Reece, Donna E.
    BLOOD, 2022, 140 : 10002 - 10004
  • [14] Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma
    Zannetti, Beatrice Anna
    Tacchetti, Paola
    Pantani, Lucia
    Gamberi, Barbara
    Tosi, Patrizia
    Rocchi, Serena
    Cellini, Claudia
    Ronconi, Sonia
    Pezzi, Annalisa
    Mancuso, Katia
    Rizzello, Ilaria
    Caratozzolo, Isola
    Martello, Marina
    Dozza, Luca
    Cavo, Michele
    Zamagni, Elena
    ANNALS OF HEMATOLOGY, 2017, 96 (12) : 2071 - 2078
  • [15] Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma
    Beatrice Anna Zannetti
    Paola Tacchetti
    Lucia Pantani
    Barbara Gamberi
    Patrizia Tosi
    Serena Rocchi
    Claudia Cellini
    Sonia Ronconi
    Annalisa Pezzi
    Katia Mancuso
    Ilaria Rizzello
    Isola Caratozzolo
    Marina Martello
    Luca Dozza
    Michele Cavo
    Elena Zamagni
    Annals of Hematology, 2017, 96 : 2071 - 2078
  • [16] Efficacy and safety of autologous stem cell transplantation in patients aged ≥ 65 years with multiple myeloma in the era of novel agents
    Shohei Mizuno
    Koji Kawamura
    Ichiro Hanamura
    Kazutaka Sunami
    Takehiko Mori
    Fumihiko Nakamura
    Shinsuke Iida
    Hideyuki Nakazawa
    Masanori Makita
    Shinichi Kako
    Masashi Sawa
    Yasunori Ueda
    Hiroyuki Takahashi
    Yoshinobu Kanda
    Tatsuo Ichinohe
    Yoshiko Atsuta
    Hiroyuki Takamatsu
    Akiyoshi Takami
    Bone Marrow Transplantation, 2019, 54 : 1595 - 1604
  • [17] Efficacy and safety of autologous stem cell transplantation in patients aged ≥ 65 years with multiple myeloma in the era of novel agents
    Mizuno, Shohei
    Kawamura, Koji
    Hanamura, Ichiro
    Sunami, Kazutaka
    Mori, Takehiko
    Nakamura, Fumihiko
    Iida, Shinsuke
    Nakazawa, Hideyuki
    Makita, Masanori
    Kako, Shinichi
    Sawa, Masashi
    Ueda, Yasunori
    Takahashil, Hiroyuki
    Kanda, Yoshinobu
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Takamatsu, Hiroyuki
    Takami, Akiyoshi
    BONE MARROW TRANSPLANTATION, 2019, 54 (10) : 1595 - 1604
  • [18] The impact of novel therapeutic agents before and after frontline autologous stem cell transplantation in patients with multiple myeloma
    Min, Chang-Ki
    Lee, Sung-Eun
    Yahng, Seung-Ah
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Kim, Hee-Je
    Lee, Seok
    Cho, Seok-Goo
    Kim, Dong-Wook
    Lee, Jong-Wook
    Min, Woo-Sung
    Park, Chong-Won
    BLOOD RESEARCH, 2013, 48 (03) : 198 - 205
  • [19] AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA IN THE ERA OF NOVEL AGENTS: IMPACT OF DEPTH OF RESPONSE TO INDUCTION THERAPY. A SINGLE INSTITUTION EXPERIENCE
    Tapia, M. G.
    Olarte, K.
    Mckinnon, R.
    Ruemenapp, K.
    Janakiraman, N.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S203 - S203
  • [20] Depth of Response with Stem Cell Transplantation and Outcome for Multiple Myeloma in the Era of Novel Agents
    Dingli, David
    Gay, Francesca
    Buadi, Francis
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Kumar, Shaji
    Lacy, Martha Q.
    Russell, Stephen J.
    Rajkumar, Vincent
    Gertz, Morie
    BLOOD, 2009, 114 (22) : 506 - 506
12345